Status:

NOT_YET_RECRUITING

VitaFlow® Transcatheter Aortic Valve Replacement System Pre-market Trial Long Term Follow Up (VITAL)

Lead Sponsor:

Shanghai MicroPort CardioFlow Medtech Co., Ltd.

Conditions:

Aortic Valve Disease

Aortic Valve Stenosis

Eligibility:

All Genders

18+ years

Brief Summary

This study is an observational study to evaluate the long-term safety and effectiveness of the valve system.

Detailed Description

This study is an observational study, for who have joined the VitaFlow® Catheter Aortic Valve System pre-market trial (Protocol No. valve -2014-04) in 4 designated research institutions, and follow-up...

Eligibility Criteria

Inclusion

  • Must meet 1, 2, 3, 4 or 1, 5 to be selected:
  • Patients who have participated in the VitaFlow® transcatheter aortic valve system pre-market trial in the 4 designated research institutions\*;
  • Be able to get in touch with the patient or his legal guardian/relative;
  • Patients who can understand the purpose and nature of the follow-up of this study, and are willing to cooperate with the follow-up and provide follow-up information;
  • Sign the informed consent form;
  • Patients who are known to have died.
  • 4 research institutions: Zhongshan Hospital Fudan University, Second Affiliated Hospital of Zhejiang University School of Medicine, West China Hospital of Sichuan University and Fuwai Hospital.

Exclusion

  • Participate in clinical trials of other drugs or medical devices and have not yet reached the primary endpoint;
  • The investigator judges that the patient's compliance is poor and the study cannot be completed as required.

Key Trial Info

Start Date :

July 30 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

October 30 2028

Estimated Enrollment :

89 Patients enrolled

Trial Details

Trial ID

NCT05977257

Start Date

July 30 2023

End Date

October 30 2028

Last Update

August 4 2023

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Fuwai CVD Hospital of Chinese Academy of Medical Sciences

Beijing, China

2

West China Hospital, Sichuan University

Chengdu, China

3

The Second Affiliated Hospital Zhejiang University School of Medicine

Hangzhou, China

4

Zhongshan Hospital Fudan University

Shanghai, China